US Patent Issued to The Johns Hopkins University, University of Maryland on Oct. 6 for "DNA methylation biomarkers of post-partum depression risk" (Canadian, American Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,439, issued on Oct. 6, was assigned to The Johns Hopkins University (Baltimore) and University of Maryland (Baltimore).

"DNA methylation biomarkers of post-partum depression risk" was invented by Zachary Kaminsky (Ottawa), Jennifer L. Payne (Baltimore) and Todd Gould (Baltimore).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the field of post-partum depression. More specifically, the present invention relates to the use of biomarkers to diagnose post-partum depression or predict a risk thereof. In a specific embodiment, a method for identifying a likelihood of PPD in a patient comprises the steps of (a) providing a sam...